AcelRx Pharmaceuticals, Inc. at the BIO 2017 International Convention (Replay)
06/21/17 at 11:45 a.m. PT
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock) $2.15-0.25 (10.42%)
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|
There are currently no events scheduled.
|Get help downloading or viewing the above file types|
Receive E-mail Alerts
|Sign up to receive e-mail alerts whenever AcelRx Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.|